About: http://webisa.webdatacommons.org/62554097

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	Regarding the administration mode of each CCR5 antagonist, for example, there is a method in which 30 mg/kg of the CCR5 antagonist is orally administered twice a day.
http://www.w3.org/ns/prov#wasQuotedFrom	freepatentsonline.com